Screener
Labcorp Holdings LH Q2 2026 earnings
Reported July 30, 2026 · Before market open
Revenue$3.7BBeat by $21.7M
Adjusted EPS$4.99Beat by $0.21
Revenue estimate$3.7B
EPS estimate$4.78
“During the second quarter, we expanded our leadership in oncology and other high-growth specialty areas, strengthened our position as the partner of choice for health systems, biopharmaceutical companies, and regional/local laboratories, and advanced our use of technology to improve the experience for consumers and providers. Our performance and continued execution position us well to deliver sustainable growth and long-term value for customers and shareholders.”
Earnings data and commentary were extracted with AI from company filings and may contain errors. Verify important details in the filing.
Next report
Oct 27, 2026 (in 2 months)Revenue estimate$3.8B
EPS estimate$4.63
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Labcorp Holdings report Q2 2026 earnings?
- Labcorp Holdings (LH) reported Q2 2026 earnings on July 30, 2026 before market open.
- What were Labcorp Holdings's Q2 2026 revenue and EPS?
- Labcorp Holdings reported revenue of $3.7B and adjusted eps of $4.99 for Q2 2026.
- Did Labcorp Holdings beat estimates in Q2 2026?
- Revenue beat the consensus estimate of $3.7B by $21.7M. EPS beat the consensus estimate of $4.78 by $0.21.
- How did Labcorp Holdings's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 5.8% from $3.5B a year earlier.
- Where can I find Labcorp Holdings's Q2 2026 SEC filings?
- You can read the 8-K earnings release (0000920148-26-000162) and the 10-Q periodic report (0000920148-26-000175) directly on SEC EDGAR. The filing index links above go to sec.gov.
